TEVA Teva Pharmaceutical Industries
- 16.590
- -0.220-1.31%
- 16.480
- -0.110-0.66%
Teva Pharmaceutical Industries News
Teva, Alvotech Launch Biosimilar Against AbbVie's Humira
Express News | Reported Earlier, Teva And Alvotech Announce U.S. Launch Of Simlandi (Adalimumab-ryvk), The First Interchangeable High-Concentration, Citrate-Free Biosimilar To Humira
Express News | Teva and Alvotech Announce Simlandi® (Adalimumab-Ryvk) Injection Now Available in the U.S.
Teva Pharmaceutical Industries Options Spot-On: On May 20th, 90,889 Contracts Were Traded, With 900.4K Open Interest
On May 20th ET, $Teva Pharmaceutical Industries(TEVA.US)$ had active options trading, with a total trading volume of 90,889 options for the day, of which put options accounted for 3.07% of the total t
Express News | NYSE Order Imbalance 142683.0 Shares on Buy Side
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). This shift could revolutionize the cannabis industry. B
Express News | NYSE Order Imbalance 76140.0 Shares on Sell Side
Insider Sale: Chief Accounting Officer Amir Weiss Sells 28,135 Shares of Teva Pharmaceutical ...
Teva Pharmaceutical Industries Insider Sold Shares Worth $470,794, According to a Recent SEC Filing
Amir Weiss, Chief Accounting Officer, around May 15, 2024, sold 28,135 shares in Teva Pharmaceutical Industries (TEVA) for $470,794. Following the Form 4 filing with the SEC, Weiss has control over a
Teva Pharmaceutical Industries(TEVA.US) Officer Sells US$470.79K in Common Stock
$Teva Pharmaceutical Industries(TEVA.US)$ Officer Weiss Amir sold 28,135 shares of common stock on May 15, 16, 2024 at an average price of $16.7334 for a total value of $470.79K.Source: Announcement W
Express News | NYSE Order Imbalance 56007.0 Shares on Sell Side
Teva Pharmaceutical Industries(TEVA.US) Officer Sells US$254.81K in Common Stock
$Teva Pharmaceutical Industries(TEVA.US)$ Officer Conway Vikki L sold 15,219 shares of common stock on May 13, 2024 at an average price of $16.7427 for a total value of $254.81K.Source: Announcement W
Teva Pharmaceutical Industries Insider Sold Shares Worth $254,807, According to a Recent SEC Filing
Vikki L Conway, Acting Head of Global Human Resources, on May 13, 2024, sold 15,219 shares in Teva Pharmaceutical Industries (TEVA) for $254,807. SEC Filing: https://www.sec.gov/Archives/edgar/data/81
Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
TEL AVIV, Israel--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Matthew Shields as Executive Vice President of Teva Global Operations (
David Abrams Exits Teva Pharmaceutical in Q1 2024, Reflecting Strategic Portfolio Adjustments
Express News | NYSE Order Imbalance 144325.0 Shares on Buy Side
Teva Pharmaceutical Industries Limited (TEVA) BofA Securities 2024 Health Care Conference (Transcript)
Teva Pharmaceutical Industries Limited (TEVA) BofA Securities 2024 Health Care Conference (Transcript)
Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?
Israel's Once-Dominant Drugmaker Is Revived by Innovation -- Heard on the Street -- WSJ
By David Wainer Teva Pharmaceutical, one of the world's largest makers of generic drugs, has been in the penalty box with investors for years. The crisis of confidence began in 2016, after the compan
Teva Pharmaceutical Industries Options Spot-On: On May 13th, 136.54K Contracts Were Traded, With 875.24K Open Interest
On May 13th ET, $Teva Pharmaceutical Industries(TEVA.US)$ had active options trading, with a total trading volume of 136.54K options for the day, of which put options accounted for 5.11% of the total
Analysis
Price Target
No Data
